Dr. Hellyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
875 Blake Wilbur Dr
Palo Alto, CA 94304
Education & Training
University of Colorado School of Medicine Anschutz Medical CampusClass of 2014
Certifications & Licensure
WA State Medical License 2021 - 2026
PA State Medical License 2020 - 2022
CA State Medical License 2015 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 73 citationsDurvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy.Jacqueline V. Aredo, Isa Mambetsariev, Jessica A. Hellyer, Arya Amini, Joel W. Neal
Journal of Thoracic Oncology. 2021-06-01 - 41 citationsRole of Consolidation Durvalumab in Patients With EGFR- and HER2-Mutant Unresectable Stage III NSCLC.Jessica A. Hellyer, Jacqueline V. Aredo, Millie Das, Kavitha Ramchandran, Sukhmani K. Padda
Journal of Thoracic Oncology. 2021-05-01 - 5 citationsAutoimmune Disease in Patients With Advanced Thymic Epithelial Tumors.Surbhi Singhal, Jessica Hellyer, Madhu M Ouseph, Heather A Wakelee, Sukhmani K Padda
JTO Clinical and Research Reports. 2022-05-01
Press Mentions
'We Didn't Know Some of the Cancer Risks': Free Lung Cancer Screenings Held for Firefighters AndJune 5th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
